INSIGHTS ON CLINICAL TRIAL PARTNERING
-
![clinical-storage-GettyImages-2200933670]( "The Case For Parallel Processing In Clinical Trial Start-Up")
The Case For Parallel Processing In Clinical Trial Start-UpStop letting outdated processes stall your innovation and learn how parallel processing transforms study start-up from a series of hurdles into a synchronized sprint.
-
![GettyImages-1425355912-laboratory-centrifuge-vial-samples]( "Prospecting Biospecimen Collections To Power Precision Medicine")
Prospecting Biospecimen Collections To Power Precision MedicineHigh-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.
-
![GettyImages-1435078862 esource]( "Redefining eSource: A Smarter Approach To Clinical Trial Data Capture")
Redefining eSource: A Smarter Approach To Clinical Trial Data CaptureDiscover how AI-powered extraction and site-centric workflows improve data quality and reduce administrative burdens for research teams.
-
![GettyImages-1987435635 research, planning]( "Rescuing A Global Program For NDA Success")
Rescuing A Global Program For NDA SuccessExplore the collaboration that enabled FDA approval of a novel chronic-condition therapy, rescued a high-risk program, and demonstrated a unified “one-team” approach by reworking the sponsor's SAP.
-
Who Owns The Work Behind Clinical Trial Complexity?9/3/2026
Site burden often points to unclear ownership. This article examines how recurring administrative work reaches sites, where standardization helps, and when responsibility should shift.
-
How To Optimize CMC And Clinical Strategies For Injectable, Oral Peptide Drugs3/17/2025
Advances in peptide drug delivery have opened new opportunities for peptide drug products, with non-parenteral routes of administration — such as oral and nasal — now feasible.
-
From Friction To Partnership: Becoming The Sponsor Of Choice7/17/2026
Sponsors depend on sites to recruit patients, execute protocols, and collect high-quality data. In this candid panel discussion, we explore what makes sites want to work with a sponsor.
-
Tips And Tricks For Developing Rare Cancer Clinical Trials2/6/2025
Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.
-
8 Critical Questions To Ask Your IRB2/5/2025
This article outlines eight essential questions to ask a potential IRB partner to assess their ability to help you navigate complex regulatory requirements while avoiding delays.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
![Talking-working-video-calling-GettyImages-1355529014]( "Virtual And Hybrid Meeting Solutions For Clinical Trials")
Flexibility matters. Scout helps you plan hybrid and virtual meetings that connect global teams and keep every attendee engaged.
Whether in-person, online, or both, our hybrid meeting solutions for clinical trials make collaboration simple, secure, and human.
-
![Medical Hazardous Laboratory Waste-GettyImages-1022715774]( "Destruction And Circular Services")
Optimize clinical trial logistics with sustainable lifecycle solutions that reduce waste, lower costs, and maximize laboratory equipment value.
-
![GettyImages-966266114 CRA]( "Rave TSDV - Improve CRA Efficiency And Reduce Site Burden")
Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.
-
![keyboard laptop virtual]( "Medical Writing For Clinical Trials")
For successful regulatory outcomes, we provide quality medical writing services for clinical trial documents, safety updates, and marketing applications.
-
![GettyImages-887882750 global consulting]( "Portfolio Optimization Strategic Consulting")
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape. With multiple drugs and limited funds, you need to choose the right products early. These best prospects will then generate cash and asset value to develop others.
In partnership with Health Advances, we’ll help you decide which investments will get you to an early proof of concept, which assets to advance and which to hold back, and which assets have synergies with others, whether in production, use, or market position. By the end of it all, you’ll have an effective, fully optimized portfolio.
